US Stock MarketDetailed Quotes
CANF Can-Fite BioPharma
- 2.2000
- +0.1000+4.76%
Close Nov 29 13:00 ET
- 2.2300
- +0.0300+1.36%
Post 15:55 ET
13.41MMarket Cap-846P/E (TTM)
2.2799High2.1400Low39.34KVolume2.2000Open2.1000Pre Close86.12KTurnover0.72%Turnover RatioLossP/E (Static)6.10MShares4.690052wk High5.41P/B11.98MFloat Cap1.866152wk Low--Dividend TTM5.45MShs Float1419.0000Historical High--Div YieldTTM6.66%Amplitude1.5200Historical Low2.1880Avg Price1Lot Size
About Can-Fite BioPharma Company
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.
Company Profile
SymbolCANF
Company NameCan-Fite BioPharma
Listing DateSep 10, 2012
Founded1994
CEOMr. Motti Farbstein
MarketAMEX
Employees5
Securities TypeDR
ADS Ratio1.0 : 300.0
Fiscal Year Ends12-31
Address26 Ben Gurion Street
CityRamat Gan
CountryIsrael
Zip Code5257346
Phone972-3-924-1114
Websitehttp://www.canfite.com
Company Executives
- Name
- Position
- Salary
- Motti Farbstein
- Chief Executive Officer, Chief Operating and Financial Officer
- 467.00K
- Dr. Pnina Fishman, PhD
- Chief Scientific Officer and Executive Chairman of the Board
- 703.00K
- Dr. Sari Fishman, PhD
- Vice President, Business Development
- 373.00K
- Dr. Ilan Cohn, PhD
- Director
- --
- Dr. Abraham Sartani
- Director
- --
- Yaacov Goldman
- Independent Director
- 60.00K
- Yoseph Bornstein
- Independent Director
- --
- Guy Regev
- Independent Director
- 60.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data